Steroid dependent
Showing 26 - 50 of 6,127
Brain Metastases, Adult Trial in Edmonton (Glucocorticoid therapy)
Recruiting
- Brain Metastases, Adult
- Glucocorticoid therapy
-
Edmonton, Alberta, CanadaCross Cancer Institute
Mar 30, 2021
Frequently Relapsing Nephrotic Syndrome, Steroid-Dependent Nephrotic Syndrome Trial in Shanghai (Rituximab, Mycophenolate
Withdrawn
- Frequently Relapsing Nephrotic Syndrome
- Steroid-Dependent Nephrotic Syndrome
- Rituximab
- +2 more
-
Shanghai, Shanghai, China
- +3 more
Dec 25, 2020
Chronic Graft-versus-host Disease Trial in Beijing (Hydrogen)
Recruiting
- Chronic Graft-versus-host Disease
-
Beijing, Beijing, ChinaNavy General Hospital
Jul 17, 2020
Chronic Graft-versus-host-disease Trial in Goyang-si, Incheon, Seoul (SCM-CGH, Placebo)
Recruiting
- Chronic Graft-versus-host-disease
- SCM-CGH
- Placebo
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +6 more
Sep 26, 2021
Steroid Dependent Crohn's Disease Trial in Beer Sheva, Kfar Saba, Tzrifin (Cannabidiol , synthetic form, Placebo)
Unknown status
- Steroid Dependent Crohn's Disease
- Cannabidiol , synthetic form
- Placebo
-
Beer Sheva, Israel
- +2 more
Jun 29, 2020
Idiopathic Nephrotic Syndrome Trial in Genova (Rituximab)
Completed
- Idiopathic Nephrotic Syndrome
-
Genova, ItalyIRCCS Giannina Gaslini Institute
Jul 28, 2020
Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral Trial in Canada, United States (Nilotinib)
Completed
- Bone Marrow Transplant Failure
- +2 more
-
Stanford, California
- +4 more
Apr 13, 2020
Nephrotic Syndrome Trial in Genoa (Ofatumumab, Rituximab)
Completed
- Nephrotic Syndrome
-
Genoa, Italy/GE, ItalyIRCCS Istituto Giannina Gaslini
Jul 28, 2020
Hepatitis, Drug-Induced Trial in Denmark (Mycophenolate Mofetil, Tacrolimus, Solu-Medrol)
Recruiting
- Hepatitis, Drug-Induced
- Mycophenolate Mofetil
- +3 more
-
Herlev, Copenhagen, Denmark
- +4 more
Dec 11, 2022
Hematopoietic and Lymphoid Cell Tumor Trial in Shanghai (fecal microbiome transplantation)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- fecal microbiome transplantation
-
Shanghai, Shanghai, China
- +1 more
Apr 17, 2020
GVHD Trial in Sacramento (Bortezomib)
Completed
- Graft Versus Host Disease
-
Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
May 26, 2020
First Manifestation of Steroid Sensitive Nephrotic Syndrome Trial in Paris (Levamisole Hydrochloride, Placebo)
Completed
- First Manifestation of Steroid Sensitive Nephrotic Syndrome
- Levamisole Hydrochloride
- Placebo
-
Paris, FranceHôpital Robert Debré
Jun 7, 2022
Intestinal GVHD Trial in Seattle (procedure, biological, dietary supplement, other)
Not yet recruiting
- Intestinal Graft Versus Host Disease
- Colonoscopy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 25, 2023
Immune-related Adverse Events Refractory to Standard Therapy and
Recruiting
- Immune-related Adverse Event
- Extracorporeal photopheresis
- Other immunosuppressive or immunomodulatory drugs
-
Munich, GermanyLMU Klinikum Hauttumorzentrum
Jan 17, 2023
Steroid-Sensitive Nephrotic Syndrome Trial in Shanghai (Rituximab, Corticosteroid)
Not yet recruiting
- Steroid-Sensitive Nephrotic Syndrome
-
Shanghai, Shanghai, China
- +2 more
May 6, 2023
GVHD Trial in Minneapolis (Pregnyl®)
Active, not recruiting
- Graft vs Host Disease
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 3, 2022
Ulcerative Colitis Trial in Portugal, Spain (Adacolumn)
Recruiting
- Ulcerative Colitis
- Adacolumn
-
Coimbra, Portugal
- +9 more
Jun 22, 2022
Carpal Tunnel Syndrome Trial in Assiut (Dexamethasone, Glucose Injection)
Recruiting
- Carpal Tunnel Syndrome
- Dexamethasone
- Glucose Injection
-
Assiut, EgyptAssiut University Hospital
Aug 10, 2022
High-dose Methylprednisolone in Fast-track Total Knee
Completed
- Infection of Total Knee Joint Prosthesis
-
Aarhus, Judland, Denmark
- +6 more
May 6, 2022
Chronic GVHD After HCT for Cancer or Immune Disease Trial in Montreal (Autologous peripheral blood mononuclear cells ex vivo
Unknown status
- Chronic GVHD After HCT for Cancer or Immune Disease
- Autologous peripheral blood mononuclear cells ex vivo depleted for reactive T cells, using TH9402 based photodynamic therapy, in a final formulation of 10% DMSO, 30% autologous plasma in PlasmaLyte.
-
Montreal, Quebec, CanadaHospital Maissoneuve
Aug 12, 2019
Asthma Trial in Paris (Attempt to withdrawal OMA treatment, Continuation of OMA treatment)
Recruiting
- Asthma
- Attempt to withdrawal OMA treatment
- Continuation of OMA treatment
-
Paris, Île De France, FranceHöpital Bichat-Claude Bernard
Feb 9, 2022